drugset / Trial / NCT03229551

Xylitol for Chronic Sinusitis

NCT03229551

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this investigation is to conduct a randomized controlled trial within a subgroup of difficult-to-treat patients with CRS, evaluating the use of topical xylitol treatment concurrently with topical steroid/antibiotics combination in the effort to disrupt biofilms and improve disease control. The effectiveness of topical surfactants is a research gap in treating CRS but has promising correlates in other medical fields. Specifically, the investigators will be studying the effect of topical xylitol therapy on biofilm production with the use of PCR bacterial sequencing before and after medical intervention.

Timeline

Start
2018-03-01
Primary completion
2018-07-16
Completion
2018-07-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Xylitol Small molecule 5 % Intranasal